Breakthrough £90,000 Alzheimer's drugs unlikely to benefit patients.

Breakthrough £90,000 Alzheimer's drugs unlikely to benefit patients.

BBC 16^thApril 2026.

https://www.bbc.com/news/articles/cql77wlqlx7o

For families living with Alzheimer’s, the hardest part is often the gap between hopeful headlines and everyday reality. These new drugs cited in the recent BBC report may sound like a breakthrough, but the real benefits appear small, while the burden can be very large: hospital visits every few weeks, repeated brainscans, side effects, and huge costs. Most importantly, they are not harmless. These treatments can cause brain swelling and brain bleeding, and in a small number of cases, patients have died. When someone you love is already vulnerable, that is not a minor detail. Families deserve honesty, not hype. Slowing decline a little on a clinical chart is not the same as giving someone back their memory, independence, or sense of self.

There is another reason to be cautious. One of the most remarkable Alzheimer’s studies ever carried out, the Nun Study, showed that some people can have significant Alzheimer’s changes in the brain and still remain mentally sharp. In other words, amyloid build-up does not always lead neatly or directly to obvious cognitive decline. That matters because these drugs are built around the idea that removing amyloid should meaningfully help people. But if amyloid alone does not fully explain who declines and who does not, we are right to question whether clearing it is enough. That does not mean the science is worthless, but families affected by Alzheimer’s do not need exaggerated promises. They need treatments that make a real difference to the person they love, and so far, these drugs do not clearly meet that test.

What matters most to us is not false hope but helping people live as well as possible now. While there is still no widely available treatment that can reverse Alzheimer’s, truly stop it in its tracks, or clearly improve day-to-day quality of life, we believe deeply in the value of keeping people active, connected and involved in ordinary life. Staying engaged with family, friends and the wider community, taking part in meaningful activities, and supporting confidence, routine and independence wherever possible can make a real difference to wellbeing. That is why our work focuses on helping people remainpart of life, not apart from it, and on giving every person the best possible quality of life.

https://www.nejm.org/doi/10.1056/NEJMoa2212948

https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.12213

Every article I publish reflects my personal views, informed by the evidence available at the time of writing. My aim is to support honest, compassionate and informed discussion, not to provide individual medical advice.

Kevin Hewlett MBE MSc (Dementia)

‍